Present and future fertility preservation strategies for female cancer patients

Obstetrical and Gynecological Survey

Volumn 63, Issue 11, 2008, Pages 725-732

  Georgescu, Elena S ^a   Goldberg, Jeffrey M ^a   Du Plessis, Stefan S ^b   Agarwal, Ashok ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PROCARBAZINE; SARCOLYSIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CRYOPRESERVATION; FEMALE FERTILITY; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; GAMETE; GONADAL DISEASE; HUMAN; NONHUMAN; OOCYTE; OOCYTE RETRIEVAL; OVARIAN PRESERVATION; OVARY FOLLICLE MATURATION; OVARY INSUFFICIENCY; REVIEW; SOMATIC CELL; SPERM; TISSUE PRESERVATION; WHOLE BODY RADIATION; XENOGRAFT; ANIMAL EMBRYO; CHEMICALLY INDUCED DISORDER; FEMALE; FEMALE INFERTILITY; FERTILITY; INFERTILITY THERAPY; METHODOLOGY; NEOPLASM; PHYSIOLOGY; PREGNANCY; PREMATURE OVARIAN FAILURE;

ANTINEOPLASTIC AGENTS; CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OOCYTES; OVARIAN FAILURE, PREMATURE; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 59649098361     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e318186aaea     Document Type: Review

References (57)

1. Oktay K, Buyuk E. Fertility preservation in women undergoing cancer treatment. Lancet 2004;363:1830.
2. Weir MM, Jan E, Colgan TJ. Interinstitutional pathology consultations. A reassessment. Am J Clin Pathol 2003;120:405-412.
3. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
4. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 1999;33:29-33. (Pubitemid 29318661)
5. Green JM, Kafetsios K, Statham HE, et al. Factor structure, validity and reliability of the Cambridge Worry Scale in a pregnant population. J Health Psychol 2003;8:753-764. (Pubitemid 37377103)
6. Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod 2004;19:477-480.
7. Familiari G, Relucenti M, Ermini M, et al. The human zona pellucida and scanning electron microscopy. Reality or artifacts? Ital J Anat Embryol 2001;106:33-41.
8. Tauchmanova L, Selleri C, Rosa GD, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002;95:1076-1084.
9. Kenney LB, Laufer MR, Grant FD, et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001;91:613-621.
10. Tangir J, Zelterman D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 2003;101:251-257. (Pubitemid 36170125)
11. Bower M, Ruštin GJ, Newlands ES, et al. Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 1998;34:1204-1207. (Pubitemid 28342110)
12. Maruta A, Matsuzaki M, Miyashita H, et al. Successful pregnancy after allogeneic bone marrow transplantation following conditioning with total body Irradiation. Bone Marrow Transplant 1995;15:637-638.
13. Bath LE, Critchley HO, Chambers SE, et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replcement. Br J Obstet Gynaecol 1999;106:1265-1272.
14. Oehninger S. Strategies for fertility preservation in female and male cancer survivors. J Soc Gynecol Investig 2005;12:222-231.
15. Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997;29:199-206.
16. Maltaris T, Koelbl H, Fischl F, et al. Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy. Anticancer Res 2006;26: 4171-4176.
17. Blumenfeld Z, Dann E, Avivi I, et al. Fertility after treatment for Hodgkin's disease. Ann Oncol 2002;13(suppl 1):138-147.
18. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000;169:123-131. (Pubitemid 32063311)
19. Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 1987;19:159-162. (Pubitemid 17059373)
20. Oktay K, Sonmezer M, Oktem O, et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapyinduced gonadal injury. Oncologist 2007;12:1055-1066. (Pubitemid 350007017)
21. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2005; 23:7555-7564.
22. Morita Y, Tilly JL. Oocyte apoptosis: like sand through an hourglass. Dev Biol 1999;213:1-17.
23. Morita Y, Perez Gl, Paris F, et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 2000;6:1109-1114.
24. Paris F, Perez Gl, Fuks Z, et al. Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med 2002;8:901-902.
25. Falcone T, Attaran M, Bedaiwy MA, et al. Ovarian function preservation in the cancer patient. Fertil Steril 2004;81:243-257. (Pubitemid 38223894)
26. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 2003;188:367-370. (Pubitemid 36249972)
27. Morice P, Castaigne D, Haie-Meder C, et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fértil Steril 1998;70:956-960. (Pubitemid 28499096)
28. Martin JR, Kodaman P, Oktay K, et al. Ovarian cryopreservation with transposition of a contralateral ovary: a combined approach for fertility preservation in women receiving pelvic radiation. Fértil Steril 2007;87:189.e185-e187.
29. Son WY, Yoon SH, Yoon HJ, et al. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod 2003;18:137-139.
30. Abusief ME, Hornstein MD, Jain T. Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. Fertil Steril 2007; 87:88-92.
31. Gosden RG. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 2005;60-63.
32. Oktay K, Sonmezer M. Fertility preservation In gynecologic cancers. Curr Opin Oncol 2007;19:506-511.
33. Chian RC, Lim JH, Tan SL. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 2004;16:211-219.
34. Tucker MJ, Wright G, Morton PC, et al. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil Steril 1998;70:578-579.
35. Huang JY, Tulandi T, Holzer H, et al. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fértil Steril 2008;89:567-572. (Pubitemid 351335045)
36. Li YB, Zhou CQ, Yang GF, et al. Modified vitrification method for cryopreservation of human ovarian tissues. Chin Med J (Engl) 2007;120:110-114.
37. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000; 342:1919. (Pubitemid 30419063)
38. Radford JA, Lieberman BA, Brison DR, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet 2001;357:1172-1175.
39. Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840. (Pubitemid 38368830)
40. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410. (Pubitemid 39370715)
41. Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection? Hum Reprod 2006;21:1345-1348.
42. Lucifera D, Mertineit C, Clarke HJ, et al. Methylation dynamics of imprinted genes in mouse germ cells. Genomics 2002;79: 530-538. (Pubitemid 34274294)
43. Kim SS, Battaglia DE, Soules MR. The future of human ovarian cryopreservation and transplantation: fertility and beyond. Fertil Steril 2001;75:1049-1056. (Pubitemid 32522597)
44. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353:318-321.
45. Rosendahl M, Loft A, Byskov AG, et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod 2006;21:2006-2009.
46. Martinez-Madrid VMD, Camboni A, Dolmans MM, et al. Apoptosis and ultrastructural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril 2007;87:1153-1165. (Pubitemid 46659931)
47. Shaw JM, Bowles J, Koopman P, et al. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996;11: 1668-1673. (Pubitemid 26318907)
48. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-266.
49. Tsai MC, Takeuchi T, Bedford JM, et al. Alternative sources of gametes: reality or science fiction? Hum Reprod 2000;15: 988-998.
50. Holzer H, Scharf E, Chian RC, et al. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertil Steril 2007;88:62-67.
51. Nagy ZP, Chang CC. Artificial gametes. Theriogenology 2007; 67:99-104.
52. Takeuchi T, Neri QV, Palermo GD. Construction and fertilization of reconstituted human oocytes. Reprod Biomed Online 2005;11:309-318. (Pubitemid 41269570)
53. Nagy ZP, Chang CC. Current advances in artificial gametes. Reprod Biomed Online 2005;11:332-339.
54. Maltaris T, Seufert R, Fischl F, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 2007;130:148-155.
55. Stallmach A, Wittig BM, Moser C, et al. Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut 2003;52:377-382.
56. Gladstone DE, Prestrud AA, Pradhan A, et al. High-dose cyclophosphamide for severe systemic lupus erythematosus. Lupus 2002;11:405-410.
57. Litzow MR, Perez WS, Klein JP, et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphancyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol 2002;119:1115-1124.